Thomas Schroeter
Pfizer (United States) · 14 works · 573 citations · h-index 8
Top works
- Isoform and Splice-Variant Specific Functions of Dynamin-2 Revealed by Analysis of Conditional Knock-Out Cells
- Developing predictive assays: The phenotypic screening “rule of 3”
- Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity
- High throughput glutathione and Nrf2 assays to assess chemical and biological reactivity of cysteine-reactive compounds
- Human Pluripotent Stem Cell–Derived Kidney Model for Nephrotoxicity Studies
- Inhibition of Hepatobiliary Transport Activity by the Antibacterial Agent Fusidic Acid: Insights into Factors Contributing to Conjugated Hyperbilirubinemia/Cholestasis
- Deployment of In Silico and In Vitro Safety Assays in Early-Stage Drug Discovery
- Assessment of Bile Salt Export Pump (BSEP) Inhibition in Membrane Vesicles Using Radioactive and LC/MS‐Based Detection Methods
- Positioning Enzyme- and Transporter-Based Precipitant Drug–Drug Interaction Studies in Drug Design
- Target promiscuity and physicochemical properties contribute to pharmacologically induced ER-stress
- A Predictive Nuclear Translocation Assay for Spliced X-Box–Binding Protein 1 Identifies Compounds with Known Organ Toxicities
- Comparative study of absorption prediction using human intestinal organoid-derived cells in static and flow conditions
- Assay Translation of Preclinical Cardiovascular (CV) Assessments
- Evaluation of a Long-Term Human Hepatocyte Culture Maintained in PowerHEP Maintenance Medium for Drug Clearance Prediction